FindTrial
Sign In

We plan to build a nationwide, multi-center cohort consisting of data of patients who received ECMO treatment due to severe acute respiratory failure.

Prediction of weaning from veno-venous extracorporeal membrane oxygenation in adult patients with severe acute respiratory failure: Korean Exracorporeal Lung Support Organization (KELSO) score

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0002078
Enrollment
200
Registered
2016-09-27
Start date
2016-06-01
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Asan Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Despite the best of care and proper ventilation it does not improve severe acute respiratory failure 19 years later

Exclusion criteria

Exclusion criteria: If hemodynamically unstable DNR (do not resuscitation) or, when the limit to the treatment Other If it deems inappropriate investigators

Design outcomes

Primary

MeasureTime frame
Extracorporeal circulation membrane oxidation therapy (ECMO) release—

Secondary

MeasureTime frame
28 day mortality;In hospital mortality;Overall mortality during follow-up period; Length of stay in hospital—

Countries

Korea, Republic of

Contacts

Public Contacthong sangbum

Asan Medical Center

sbhong@amc.seoul.kr+82-2-3010-3893

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026